MRNA vs ONC
Moderna, Inc. · BeOne Medicines AG
Relative return (rebased to 100)
Key stats
| Metric | MRNA | ONC |
|---|---|---|
| Price | $226.30 | $351.48 |
| Market Cap | $90.35B | $519.53B |
| P/E | — | 1810.64 |
| P/B | 13.36 | 100.41 |
| P/S | 46.47 | 97.24 |
| ROE | -41.7% | 5.5% |
| Net Margin | -145.2% | 5.4% |
| Gross Margin | — | 87.5% |
| Revenue Growth | -39.9% | 40.2% |
| Dividend Yield | — | — |
| EPS | -$7.07 | $0.19 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.